You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Renal cell carcinoma (RCC)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Renal Cell Carcinoma Trial in Birmingham (Pembrolizumab injection)

Not yet recruiting
  • Renal Cell Carcinoma
  • Pembrolizumab injection
  • Birmingham, Alabama
    University of Alabama at Birmingham
Aug 20, 2023

Advanced Renal Cell Carcinoma Trial in Beijing (ST-1898 tablets)

Recruiting
  • Advanced Renal Cell Carcinoma
  • ST-1898 tablets
  • Beijing, Beijing, China
    Peking University Cancer Hospital & Institute
Nov 6, 2023

RCC, Renal Cell Carcinoma Trial in Dallas (Cabozantinib 80 MG, Cabozantinib 40Mg Tab, Nivolumab)

Not yet recruiting
  • RCC
  • Renal Cell Carcinoma
  • Cabozantinib 80 MG
  • +2 more
  • Dallas, Texas
    UT Southwestern Medical Center
Jul 3, 2023

Renal Cell Carcinoma Trial in Houston (Sunitinib, Nephrectomy)

Active, not recruiting
  • Renal Cell Carcinoma
  • Houston, Texas
  • +1 more
Oct 11, 2022

Kidney Cancer Trial in Birmingham (Acarbose Tablets)

Not yet recruiting
  • Kidney Cancer
  • Acarbose Tablets
  • Birmingham, Alabama
    University of Alabama at Birmingham
Aug 2, 2022

Renal Cell Carcinoma (RCC) Trial in Birmingham (Trans-arterial embolization (TAE))

Not yet recruiting
  • Renal Cell Carcinoma (RCC)
  • Trans-arterial embolization (TAE)
  • Birmingham, Alabama
    University of Alabama at Birmingham
Dec 5, 2022

Renal Cell Carcinoma Trial in Iowa City (Lenvatinib, Everolimus, Partial or Radical Cytoreductive Nephrectomy)

Recruiting
  • Renal Cell Carcinoma
  • Iowa City, Iowa
    University of Iowa Hospitals and Clinics
May 4, 2022

Advanced Renal Cell Carcinoma Trial (QL1706 Plus Lenvatinib)

Not yet recruiting
  • Advanced Renal Cell Carcinoma
  • QL1706 Plus Lenvatinib
  • (no location specified)
Feb 21, 2022

Renal Cell Carcinoma Trial in Houston (Perfusion CT scan)

Active, not recruiting
  • Renal Cell Carcinoma
  • Perfusion CT scan
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Dec 6, 2022

Recurrent Renal Cell Carcinoma, Renal Cell Carcinoma Trial in Philadelphia (drug, procedure, other)

Recruiting
  • Recurrent Renal Cell Carcinoma
  • Renal Cell Carcinoma
  • Sulfur Hexafluoride Lipid Microspheres
  • +4 more
  • Philadelphia, Pennsylvania
    Sidney Kimmel Cancer Center at Thomas Jefferson University
Nov 29, 2022

Kidney Cancer Trial in Houston (Axitinib)

Active, not recruiting
Has Results
  • Kidney Cancer
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Sep 2, 2022

Primary and Metastatic Tumors in Renal Cell Carcinoma and

Recruiting
  • Renal Cell Carcinoma
  • +4 more
  • Immune checkpoint inhibitor targeting PD1
  • Philadelphia, Pennsylvania
    Fox Chase Cancer Center - Philadelphia
Jan 27, 2023

Melanoma, Hepatocellular Carcinoma (HCC), Renal Cell Carcinoma (RCC) Trial (INCB 99280 with Ipilimumab)

Not yet recruiting
  • Melanoma
  • +5 more
  • INCB 99280 with Ipilimumab
  • (no location specified)
Jun 9, 2023

Renal Cell Carcinoma, Nasopharyngeal Carcinoma, Non Hodgkin Lymphoma Trial in United States (PRO1160)

Not yet recruiting
  • Renal Cell Carcinoma
  • +2 more
  • Detroit, Michigan
  • +4 more
Jan 31, 2023

Renal Cell Carcinoma (RCC) Trial in Heidelberg (Chimeric mAb cG250, Sunitinib malate)

Terminated
Has Results
  • Renal Cell Carcinoma (RCC)
  • Chimeric monoclonal antibody cG250
  • Sunitinib malate
  • Heidelberg, Victoria, Australia
    Austin Health (Ludwig Institute Oncology Unit)
Oct 3, 2022

Renal Cancer, Renal Cell Carcinoma, Renal Cell Cancer Metastatic Trial

Recruiting
  • Renal Cancer
  • +2 more
    • Amsterdam, Noord Holland, Netherlands
      Amsterdam UMC locatie VUMC
    Jan 20, 2023

    Cancer of Kidney, Kidney Cancer, Renal Cancer Trial in New York (124-Iodine-cG250 (124I-cG250))

    Completed
    Has Results
    • Cancer of Kidney
    • +6 more
    • 124-Iodine-cG250 (124I-cG250)
    • New York, New York
      Memorial Sloan-Kettering Cancer Center
    Oct 3, 2022

    Advanced Cancer, Advanced Malignancies, Bladder Cancer Trial (AB598, Zimberelimab, Carboplatin)

    Not yet recruiting
    • Advanced Cancer
    • +11 more
    • (no location specified)
    May 26, 2023

    Implementation of Shared Decision Making Strategy for Renal Cell

    Recruiting
    • Renal Cell Carcinoma
    • Renal Cell Carcinoma Metastatic
    • Decision aid
    • Nieuwegein, Utrecht, Netherlands
      St. Antonius Ziekenhuis
    Nov 28, 2022

    Preferences of Participants and Oncologists for Characteristics

    Completed
    • Renal Cell Carcinoma
      • Castellon de La Plana, Spain
        Local Institution
      Dec 8, 2021

      Observe Onset of Immune-related Adverse Reactions in

      Completed
      • Renal Cell Carcinoma
      • Kidney Cancer
      • Non-Interventional
      • Tokyo, Japan
        Local Institution
      Feb 9, 2022

      Metastatic Renal Cell Carcinoma Trial in United Kingdom (Cyclophosphamide 50mg, Pembrolizumab 25 mg/1 ML Intravenous Solution

      Recruiting
      • Metastatic Renal Cell Carcinoma
      • Cyclophosphamide 50mg
      • Pembrolizumab 25 mg/1 ML Intravenous Solution [KEYTRUDA]
      • Cambridge, United Kingdom
      • +3 more
      Aug 22, 2022

      Renal Cell Carcinoma Trial in United States (everolimus and bevacizumab)

      Completed
      Has Results
      • Renal Cell Carcinoma
      • everolimus and bevacizumab
      • Basking Ridge, New Jersey
      • +6 more
      Jan 3, 2022

      Advanced Renal Cell Carcinoma Trial in Heilbronn (IVAC)

      Recruiting
      • Advanced Renal Cell Carcinoma
      • IVAC
      • Heilbronn, Germany
        SLK Kliniken Heilbronn, Klinik für Innere Medizin III: Hämatolog
      Nov 30, 2022

      Renal Cell Carcinoma Trial in Ireland, Sweden (Pazopanib)

      Completed
      • Renal Cell Carcinoma
      • Dublin, Leinster, Ireland
      • +8 more
      Dec 22, 2021